Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
43.30
+1.61 (3.86%)
At close: Jan 21, 2026, 4:00 PM EST
43.30
0.00 (0.00%)
After-hours: Jan 21, 2026, 6:09 PM EST
Veracyte Employees
Veracyte had 824 employees as of December 31, 2024. The number of employees increased by 9 or 1.10% compared to the previous year.
Employees
824
Change (1Y)
9
Growth (1Y)
1.10%
Revenue / Employee
$600,899
Profits / Employee
$36,792
Market Cap
3.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 824 | 9 | 1.10% |
| Dec 31, 2023 | 815 | 28 | 3.56% |
| Dec 31, 2022 | 787 | 26 | 3.42% |
| Dec 31, 2021 | 761 | 441 | 137.81% |
| Dec 31, 2020 | 320 | -34 | -9.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Charles River Laboratories International | 20,100 |
| RadNet | 9,000 |
| Sotera Health Company | 3,000 |
| Neogen | 2,974 |
| NeoGenomics | 2,200 |
| GeneDx Holdings | 1,000 |
| GRAIL | 1,000 |
| Twist Bioscience | 979 |
VCYT News
- 5 days ago - Veracyte: Profitable, De-Risked, And Ready To Run - Seeking Alpha
- 6 days ago - Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results - Business Wire
- 23 days ago - Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 2 months ago - Veracyte to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Veracyte, Inc. (VCYT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Veracyte Announces Third Quarter 2025 Financial Results - Business Wire
- 2 months ago - Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing - Business Wire